{{Rsnum
|rsid=752854
|Gene=WFS1
|Chromosome=4
|position=6280234
|Orientation=minus
|GMAF=0.1951
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=WFS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 41.6 | 6.2
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 63.9 | 31.3 | 4.8
| ASW | 68.4 | 28.1 | 3.5
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 56.4 | 40.6 | 3.0
| LWK | 68.2 | 28.2 | 3.6
| MEX | 70.7 | 27.6 | 1.7
| MKK | 58.3 | 36.5 | 5.1
| TSI | 47.1 | 39.2 | 13.7
| HapMapRevision=28
}}{{PMID|18040659|OA=1
}} the minor allele of [[rs752854]] was associated with reduced type 2 diabetes risk in European populations. odds ratio (OR) 0.85, 95% CI 0.75-0.96, p = 0.010.

{{PMID Auto
|PMID=18060660
|Title=Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}